Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Experimental Hematology & Oncology|January 5, 2021
Targeting phosphoglycerate dehydrogenase in multiple myelomaSamah Elsaadi, Ida Steiro, Pegah Abdollahi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 7, 2003
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survivalPeter I Croucher, Raeve De Hendrik, Mark J Perry, et al.
Investigative Ophthalmology & Visual Science|June 3, 2008
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptorMario A Economou, Jiangmei Wu, Daiana Vasilcanu, et al.
Plos One|July 17, 2010
Polycomb target genes are silenced in multiple myelomaAntonia Kalushkova, Mårten Fryknäs, Miguel Lemaire, et al.
Cancer Biology & Medicine|May 7, 2021
Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myelomaFengjuan Jiang, Hui Liu, Fengping Peng, et al.
Plos One|April 26, 2016
Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma PatientsLiesbeth Bieghs, Malene Brohus, Ida B Kristensen, et al.
Blood|August 4, 2010
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2Ken Maes, Elizabeta Nemeth, G David Roodman, et al.
Molecular Omics|December 8, 2021
Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myelomaEsther A Zaal, Harm-Jan de Grooth, Inge Oudaert, et al.
Pageof 17